10-26096461-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_017433.5(MYO3A):c.1643C>T(p.Pro548Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000149 in 1,613,530 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P548H) has been classified as Likely benign.
Frequency
Consequence
NM_017433.5 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 30Inheritance: AR, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal dominant 90Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYO3A | NM_017433.5 | c.1643C>T | p.Pro548Leu | missense_variant | Exon 16 of 35 | ENST00000642920.2 | NP_059129.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYO3A | ENST00000642920.2 | c.1643C>T | p.Pro548Leu | missense_variant | Exon 16 of 35 | NM_017433.5 | ENSP00000495965.1 | |||
| MYO3A | ENST00000543632.5 | c.1643C>T | p.Pro548Leu | missense_variant | Exon 15 of 17 | 1 | ENSP00000445909.1 | |||
| MYO3A | ENST00000642197.1 | n.1847C>T | non_coding_transcript_exon_variant | Exon 16 of 27 | ||||||
| MYO3A | ENST00000647478.1 | n.1643C>T | non_coding_transcript_exon_variant | Exon 15 of 30 | ENSP00000493932.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152108Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 250834 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461422Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727018 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74320 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Pro548Leu variant in MYO3A has not been previously reported in individuals with hearing loss, but has been identified in 5/126754 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs143918373). Computational prediction tools and conservation analyses do not p rovide strong support for or against an impact to the protein. In summary, the c linical significance of the p.Pro548Leu variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.1643C>T (p.P548L) alteration is located in exon 16 (coding exon 14) of the MYO3A gene. This alteration results from a C to T substitution at nucleotide position 1643, causing the proline (P) at amino acid position 548 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at